Paper730378
Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.
Wachter RF and 2 others. Infect Immun, 1978. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii. Papers, record 730378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/730378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Antigens, Bacterial | Major topic |
| Coxiella | Major topic |
| Animals | |
| Bacterial Vaccines | |
| Carboxymethylcellulose Sodium | |
| Guinea Pigs | |
| Poly I-C | |
| Polylysine | |
| Q Fever |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14482335 | Antigens of Coxiella burnetii. I. Extraction of antigens with non-aqueous organic solvents. | J Immunol | 1962 | https://conductscience.org/library/papers/14482335 | PubMed |
| 2 | 408923 | Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. | Science | 1977 | https://conductscience.org/library/papers/408923 | PubMed |
| 3 | 407312 | Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). | J Infect Dis | 1977 | https://conductscience.org/library/papers/407312 | PubMed |
| 4 | 820645 | Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. | Infect Immun | 1976 | https://conductscience.org/library/papers/820645 | PubMed |
| 5 | 4102398 | Regulation of the immune system by synthetic polynucleotides. I. Characteristics of adjuvant action on antibody synthesis. | J Immunol | 1971 | https://conductscience.org/library/papers/4102398 | PubMed |
| 6 | 4755168 | Immunization in man with a soluble Q fever vaccine. | Arch Roum Pathol Exp Microbiol | 1973 | https://conductscience.org/library/papers/4755168 | PubMed |
| 7 | 970938 | Preparation of phase 1Q fever antigen suitable for vaccine use. | Appl Environ Microbiol | 1976 | https://conductscience.org/library/papers/970938 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 18701647 | Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii. | Clin Vaccine Immunol | 2008 | https://conductscience.org/library/papers/18701647 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/730378
GET https://conductscience.org/api/papers/v1/730378/authors